A detailed history of Fieldpoint Private Securities, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 5 shares of ZLAB stock, worth $118. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 30 83.33%
Holding current value
$118
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$23.14 - $49.68 $578 - $1,242
-25 Reduced 83.33%
5 $0
Q1 2022

Apr 07, 2022

SELL
$27.77 - $64.4 $1,527 - $3,542
-55 Reduced 64.71%
30 $1,000
Q3 2021

Nov 12, 2021

BUY
$105.0 - $178.37 $525 - $891
5 Added 6.25%
85 $9,000
Q2 2021

Aug 12, 2021

SELL
$125.11 - $180.0 $1,876 - $2,700
-15 Reduced 15.79%
80 $12,000
Q1 2021

Apr 23, 2021

BUY
$126.27 - $191.71 $5,050 - $7,668
40 Added 72.73%
95 $13,000
Q4 2020

Jan 28, 2021

BUY
$81.94 - $135.34 $4,506 - $7,443
55 New
55 $7,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.31B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.